Lessons learned from good manufacturing practice noncompliance.
作者信息
Peskoe M P
机构信息
American Home Products Corporation, Madison, NJ, USA.
出版信息
Food Drug Law J. 1995;50(1):65-70.
PMID:10342986
Abstract
摘要
相似文献
1
Lessons learned from good manufacturing practice noncompliance.从药品生产质量管理规范违规行为中吸取的教训。
Food Drug Law J. 1995;50(1):65-70.
2
The learned intermediary doctrine: past, present and future.知悉中介原则：过去、现在与未来。
Leg Med. 1994:269-80.
3
Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.成品药品现行良好生产规范法规修正案。直接最终规则。
Fed Regist. 2007 Dec 4;72(232):68064-70.
4
Quality control and good manufacturing practices: safety and efficacy of commercial herbals.
Food Drug Law J. 1997;52(3):341-4.
5
The federal preemption debate in pharmaceutical labeling product liability actions.药品标签产品责任诉讼中的联邦优先适用权辩论。
Tort Trial Insur Pract Law J. 2007 Fall;43(1):35-70.
6
A millstone in the uphill battle for credibility.在争取可信度的艰苦战斗中的一块绊脚石。
Altern Med Rev. 2001 Feb;6(1):3.
7
A defense of the learned intermediary doctrine.对知悉中介原则的辩护。
Food Drug Law J. 2008;63(2):421-38.
8
The case for preemption of prescription drug failure-to-warn claims.处方药未警示索赔的优先适用情形。
Food Drug Law J. 2007;62(2):399-422.
9
Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.避孕药的消费者导向型广告：美国食品药品监督管理局、醋酸甲羟孕酮注射液与产品责任
Food Drug Law J. 1995;50(4):553-67.
10
Vioxx, radiology, and the Food and Drug Administration.
J Am Coll Radiol. 2005 May;2(5):394-7. doi: 10.1016/j.jacr.2005.01.019.
Zotero 插件